Subtopic Deep Dive
Artemisinin Resistance Mechanisms
Research Guide
What is Artemisinin Resistance Mechanisms?
Artemisinin resistance mechanisms refer to genetic mutations in Plasmodium falciparum, primarily Pfkelch13 propeller domain variants, conferring delayed parasite clearance and reduced artemisinin efficacy in clinical isolates.
Resistance first emerged in Southeast Asia, linked to kelch13 mutations enabling prolonged ring-stage survival (Ariey et al., 2013; 2075 citations). These mutations spread across mainland regions and clonal expansions occur via local transmission (Ashley et al., 2014; 2115 citations). Recent detections in Africa highlight independent emergences (Balikagala et al., 2021; 863 citations).
Why It Matters
Artemisinin resistance threatens global malaria control as the cornerstone of artemisinin-based combination therapies (ACTs), the WHO-recommended frontline treatment (Ashley et al., 2014). Surveillance of kelch13 markers enables early detection and containment strategies, as demonstrated in Rwanda's clonal R561H expansion (Uwimana et al., 2020). Understanding fitness costs and partner drug interactions informs next-generation therapies, preventing widespread treatment failures seen historically with chloroquine (Sidhu et al., 2002).
Key Research Challenges
Kelch13 Mutation Diversity
Multiple propeller domain mutations like R561H confer varying resistance levels across regions (Uwimana et al., 2020). Distinguishing causal from passenger mutations requires functional validation beyond association studies (Straimer et al., 2014). Surveillance struggles with novel variants emerging independently in Africa (Balikagala et al., 2021).
Fitness Cost Assessment
Resistant parasites often show reduced transmission fitness, complicating spread modeling (Ashley et al., 2014). Measuring growth rates and gametocytogenesis in kelch13 mutants demands longitudinal field data (Ariey et al., 2013). Balancing resistance gains against transmission losses predicts geographic expansion (White, 2004).
Combination Therapy Efficacy
Partner drugs in ACTs face delayed recrudescence from artemisinin partial resistance (Straimer et al., 2014). Cross-resistance via transporters like Pgh1 affects multiple antimalarials (Reed et al., 2000). Optimizing regimens requires pharmacodynamic models integrating resistance markers.
Essential Papers
Spread of Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria
Elizabeth A. Ashley, Mehul Dhorda, Rick M. Fairhurst et al. · 2014 · New England Journal of Medicine · 2.1K citations
Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is associated with mutations in kelch13. Prolonged courses of artemisinin-based combination therapies...
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frédéric Ariey, Benoît Witkowski, Chanaki Amaratunga et al. · 2013 · Nature · 2.1K citations
Antimalarial drug resistance
Nicholas J. White · 2004 · Journal of Clinical Investigation · 1.1K citations
Malaria, the most prevalent and most pernicious parasitic disease of humans, is estimated to kill between one and two million people, mainly children, each year. Resistance has emerged to all class...
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Jane Achan, Ambrose Talisuna, Annette Erhart et al. · 2011 · Malaria Journal · 944 citations
Evidence of Artemisinin-Resistant Malaria in Africa
Betty Balikagala, Naoyuki Fukuda, Mie Ikeda et al. · 2021 · New England Journal of Medicine · 863 citations
The independent emergence and local spread of clinically artemisinin-resistant <i>P. falciparum</i> has been identified in Africa. The two <i>kelch13</i> mutations may be markers for detection of t...
Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
Michael B. Reed, Kevin J. Saliba, Sonia R. Caruana et al. · 2000 · Nature · 857 citations
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
Jane M. Carlton, John H. Adams, Joana C. Silva et al. · 2008 · Nature · 848 citations
Reading Guide
Foundational Papers
Start with Ariey et al. (2013) for molecular marker discovery, Ashley et al. (2014) for geographic spread evidence, and White (2004) for resistance evolution context—these establish kelch13 as causal with >5000 combined citations.
Recent Advances
Uwimana et al. (2020) for R561H clonal expansion in Rwanda; Balikagala et al. (2021) for independent African emergence—both detail surveillance needs amid ACT threats.
Core Methods
Kelch13 sequencing (Sanger/Illumina); ring-stage survival assays (7.5-hour DHA exposure); population genomics for transmission fitness (GWAS, haplotype analysis from Ashley et al., 2014; Straimer et al., 2014).
How PapersFlow Helps You Research Artemisinin Resistance Mechanisms
Discover & Search
Research Agent uses searchPapers('kelch13 mutations artemisinin resistance') to retrieve Ashley et al. (2014) and citationGraph to map spread from Ariey et al. (2013) to regional studies. exaSearch uncovers unpublished preprints on African emergences, while findSimilarPapers expands from Uwimana et al. (2020) to clonal expansion analyses.
Analyze & Verify
Analysis Agent employs readPaperContent on Ashley et al. (2014) to extract kelch13 prevalence data, then runPythonAnalysis for survival curve statistics from ring-stage assays. verifyResponse with CoVe cross-checks mutation fitness claims against Straimer et al. (2014), with GRADE grading for evidence quality on clinical efficacy.
Synthesize & Write
Synthesis Agent detects gaps in African resistance modeling post-Balikagala et al. (2021), flags kelch13 vs. transporter contradictions. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations for 20+ papers, and latexCompile for camera-ready outputs; exportMermaid visualizes resistance spread timelines.
Use Cases
"Model fitness costs of Pfkelch13 R561H mutants using ring-stage survival data"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted assay data from Uwimana et al., 2020) → growth rate plots and statistical comparisons.
"Draft surveillance protocol for artemisinin resistance markers in Africa"
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (resistance maps) → latexSyncCitations (Balikagala et al., 2021; Ashley et al., 2014) → latexCompile → PDF protocol.
"Find code for Plasmodium genomic analysis of kelch13 variants"
Research Agent → paperExtractUrls (Uwimana et al., 2020) → Code Discovery → paperFindGithubRepo → githubRepoInspect → variant calling scripts and GWAS pipelines.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ kelch13 papers: searchPapers → citationGraph → DeepScan (7-step verification with CoVe checkpoints on mutation causality). Theorizer generates hypotheses on fitness trade-offs from Ashley et al. (2014) and Straimer et al. (2014), chaining runPythonAnalysis for simulations.
Frequently Asked Questions
What defines artemisinin resistance?
Delayed parasite clearance (≥5 hours ring-stage survival) in artemisinin monotherapy, phenotypically linked to Pfkelch13 mutations (Ariey et al., 2013).
What are key methods for detection?
Molecular: kelch13 propeller sequencing; phenotypic: in vitro ring-stage survival assay (RSA0-3h); clinical: ≥3% Day 3 parasitemia (Ashley et al., 2014).
What are seminal papers?
Ariey et al. (2013, Nature, 2075 citations) identified C580Y marker; Ashley et al. (2014, NEJM, 2115 citations) mapped Southeast Asian spread; Straimer et al. (2014, Science) validated causality.
What open problems remain?
Fitness costs in diverse genetic backgrounds; cross-resistance predictors beyond kelch13; containment strategies for African emergences (Balikagala et al., 2021; Uwimana et al., 2020).
Research Malaria Research and Control with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Artemisinin Resistance Mechanisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Malaria Research and Control Research Guide